Literature DB >> 13000058

Levels of homotypic neutralizing antibody in human poliomyelitis three years after infection.

J WINSSER, A B SABIN.   

Abstract

Quantitative neutralization tests in monkeys were carried out on sera obtained from 7 patients, 3 months, and 3 years after an attack of poliomyelitis. The serum specimens were tested against 100 to 1000 PD(50) of the patient's own strain of virus, recovered during the acute phase of the illness; all the strains were Type 1. The 6 patients, aged 6 months to 13 years, who had a paralytic attack of the disease, all exhibited very high levels of neutralizing antibody at 3 years as well as at 3 months after onset. The 50 per cent serum dilution titers ranged from about 1:180 to at least 1:860. Since the maximum titers were not established, it is not known to what extent, if any, the level of antibody may have dropped over the 3 year period. One of the patients, with a diagnosis of non-paralytic poliomyelitis, had a negligible or questionable antibody response during convalescence and no demonstrable antibody at 3 years; there is justifiable doubt as to whether the Type 1 poliomyelitis virus recovered from this patient had actually caused infection. Tests for Lansing neutralizing antibody indicated that the 5 patients who had no evidence of previous infection with Type 2 poliomyelitis virus had not become infected with it during the 3 year period. This suggested that these patients did not live in an environment in which infection with poliomyelitis virus is frequent. It is concluded, therefore, that in human beings, paralytic infections due to Type 1 poliomyelitis virus produce large amounts of homotypic neutralizing antibody, which persists at high levels for a period of at least 3 years.

Entities:  

Keywords:  POLIOMYELITIS/immunity

Mesh:

Substances:

Year:  1952        PMID: 13000058      PMCID: PMC2136158          DOI: 10.1084/jem.96.5.477

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Antibodies to three different antigenic types of poliomyelitis virus in sera from North Alaskan Eskimos.

Authors:  J R PAUL; J T RIORDAN; J L MELNICK
Journal:  Am J Hyg       Date:  1951-09

2.  Serum neutralizing antibodies to the infecting strain of virus in poliomyelitis patients.

Authors:  W M HAMMON; E C ROBERTS
Journal:  Proc Soc Exp Biol Med       Date:  1948-11

3.  Paralytic consequences of poliomyelitis infection in different parts of the world and in different population groups.

Authors:  A B SABIN
Journal:  Am J Public Health Nations Health       Date:  1951-10

4.  Passive immunity in poliomyelitis: II Lansing antibody content of human gamma globulins.

Authors:  A J RHODES; E M CLARK
Journal:  Proc Soc Exp Biol Med       Date:  1951-02

5.  Experimental studies on passive immunization against poliomyelitis. I. Protection with human gamma globulin against intramuscular inoculation, and combined passive and active immunization.

Authors:  D BODIAN
Journal:  Am J Hyg       Date:  1951-07

6.  Age incidence and seasonal development of neutralizing antibodies to lansing poliomyelitis virus.

Authors:  T B TURNER; D H HOLLANDER; S BUCKLEY; U P KOKKO; C P WINSOR
Journal:  Am J Hyg       Date:  1950-11

7.  Neutralization of three immunological types of poliomyelitis virus by human gamma globulin.

Authors:  D BODIAN
Journal:  Proc Soc Exp Biol Med       Date:  1949-10

8.  Transitory appearance of type 2 neutralizing antibody in patients infected with type 1 poliomyelitis virus.

Authors:  A B SABIN
Journal:  J Exp Med       Date:  1952-07       Impact factor: 14.307

9.  Antibody response of patients with poliomyelitis to virus recovered from their own alimentary tract.

Authors:  A J STEIGMAN; A B SABIN
Journal:  J Exp Med       Date:  1949-10       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.